1. Eriksson BK, Norgren M, McGregor K, Spratt BG, Normark BH. Group A streptococcal infections in Sweden: a comparative study of invasive and noninvasive infections and analysis of dominant T28 emm28 isolates. Clin Infect Dis. 2003; 37:1189–93.
Article
2. Shulman ST, Tanz RR, Dale JB, Beall B, Kabat W, Kabat K, et al. North American Streptococcal Pharyngitis Surveillance Group. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates. Clin Infect Dis. 2009; 49:78–84.
Article
3. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol. 1996; 34:953–8.
Article
4. Choi EH. Emergence of macrolide resistance and clinical use of macrolide antimicrobials in children. Korean J Pediatr. 2008; 51:1031–7.
Article
5. Kim S and Lee NY. Antibiotic resistance and genotypic characteristics of group a streptococci associated with acute pharyngitis in Korea. Microb Drug Resist. 2004; 10:300–5.
6. Yi YH, Choi JH, Lee HK, Lee KJ, Bae SM, Yu JY, et al. Characterization of erythromycin resistance of Streptococcus pyogenes isolated from pharyngitis patients in Korea. Jpn J Infect Dis. 2006; 59:192–4.
7. Chang H, Shen X, Fu Z, Liu L, Shen Y, Liu X, et al. Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China. Scand J Infect Dis. 2010; 42:84–9.
Article
8. Katz KC, McGeer AJ, Duncan CL, Ashi-Sulaiman A, Willey BM, Sarabia A, et al. Emergence of macrolide resistance in throat culture isolates of group a streptococci in Ontario, Canada, in 2001. Antimicrob Agents Chemother. 2003; 47:2370–2.
Article
9. Pérez-Trallero E, Montes M, Orden B, Tamayo E, García-Arenzana JM, Marimón JM. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005. Antimicrob Agents Chemother. 2007; 51:1228–33.
10. Murakami J, Kawabata S, Terao Y, Kikuchi K, Totsuka K, Tamaru A, et al. Distribution of emm genotypes and superantigen genes of Streptococcus pyogenes isolated in Japan, 1994-9. Epidemiol Infect. 2002; 128:397–404.
Article
11. Lee SY, Lee JS, Lee MA, Chung WS, Kim SJ. Streptococcal toxic shock syndrome associated with intrauterine fetal death: a case report. Korean J Clin Microbiol. 1998; 1:109–12.
12. Chan JC, Chu YW, Chu MY, Cheung TK, Lo JY. Epidemiological analysis of Streptococcus pyogenes infections in Hong Kong. Pathology. 2009; 41:681–6.
Article
13. McNeil SA, Halperin SA, Langley JM, Smith B, Warren A, Sharratt GP, et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis. 2005; 41:1114–22.
Article
14. Koh E and Kim S. Decline in erythromycin resistance in group a streptococci from acute pharyngitis due to changes in the emm genotypes rather than restriction of antibiotic use. Korean J Lab Med. 2010; 30:485–90.
15. Oliver MA, García-Delafuente C, Cano ME, Pérez-Hernández F, Martínez-Martínez L, Albertí S. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain). J Antimicrob Chemother. 2007; 60:450–2.
Article
16. Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, et al. Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008). J Antimicrob Chemother. 2010; 65:634–43.
Article
17. Seppälä H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med. 1997; 337:441–6.
18. Bass JW, Weisse ME, Plymyer MR, Murphy S, Eberly BJ. Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Comparison with worldwide reports. Arch Pediatr Adolesc Med. 1994; 148:67–71.
19. Green MD, Beall B, Marcon MJ, Allen CH, Bradley JS, Dashefsky B, et al. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA. J Antimicrob Chemother. 2006; 57:1240–3.
Article